| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2004.06.924 |
| P698 | PubMed publication ID | 15326196 |
| P2093 | author name string | Marc Buyse | |
| Pascal Piedbois | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 3839-3841 | |
| P577 | publication date | 2004-08-23 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Meta-analyses based on abstracted data: a step in the right direction, but only a first step. | |
| P478 | volume | 22 |
| Q36857419 | A valid formulation of the analysis of noninferiority trials under random effects meta-analysis |
| Q42081039 | Activated protein C in sepsis: down but not out, yet. |
| Q61899595 | Adjuvant chemotherapy in muscle-invasive bladder carcinoma |
| Q33396809 | Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial |
| Q43117880 | An alternative pseudolikelihood method for multivariate random-effects meta-analysis |
| Q36861597 | Aromatase inhibitors in post-menopausal metastatic breast carcinoma |
| Q61899631 | Benefit of taxanes as adjuvant chemotherapy for early breast cancer |
| Q33286793 | Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis |
| Q37930854 | Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma: an evidence-based meta-analysis |
| Q33434559 | Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer |
| Q48961346 | Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme |
| Q37015628 | Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials |
| Q44168101 | Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials |
| Q55466437 | Guidelines for the treatment of newly diagnosed glioblastoma: introduction. |
| Q47698425 | Hypomagnesemia and clinical benefits of anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer: a systematic review and meta-analysis. |
| Q44104182 | Individual patient data meta-analysis: a promising approach for evidence synthesis in reproductive medicine |
| Q24187111 | Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock |
| Q24235462 | Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock |
| Q24242133 | Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock |
| Q33851069 | Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA). |
| Q36609527 | Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients |
| Q33548385 | Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation |
| Q35578537 | Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non-small cell lung cancer: systematic review |
| Q37476857 | Management of newly diagnosed glioblastoma: guidelines development, value and application |
| Q31113128 | Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data |
| Q36653432 | Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis |
| Q28388487 | Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond |
| Q27025724 | Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review |
| Q33813436 | Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial |
| Q38228850 | Surrogate endpoints in second-line treatment for mCRC: a systematic literature-based analysis from 23 randomised trials |
| Q24801807 | The strengths and limitations of meta-analyses based on aggregate data |
Search more.